Review: Available evidence does not support a benefit for thyroid hormone replacement in adults with subclinical hypothyroidism: Commentary

Evidence-Based Medicine

Volumn 13, Issue 1, 2008, Pages 22-

  Villar, H ^a   Gharib, Hossein ^b  

^a Faculdade Estadual de Medicina de Marilia   (Brazil)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LEVOTHYROXINE; LIOTHYRONINE; PLACEBO; THYROID HORMONE; THYROTROPIN; THYROXINE;

CARDIOVASCULAR EFFECT; CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; COGNITION; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; EMBASE; EVIDENCE BASED PRACTICE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MEDLINE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT SELECTION; QUALITATIVE ANALYSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; SHORT SURVEY; SYMPTOM; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 39049145111     PISSN: 13565524     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebm.13.1.22     Document Type: Short Survey

References (2)

1. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004:291: 228-38.
2. Gharib H, Tuttle RM, Baskin HJ, et al. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 2005:90:581-5.